CORhum - Morbidity-mortality of COVID-19 in patients with chronic rheumatic disorder treated with immunosuppressants

Head :
LETAROUILLY Jean-Guillaume

Last update : 05/05/2021 | Version : 1 | ID : 73495

print
Print
xml
XML

Export to XML

Please choose the format :

pdf
PDF
xml
CSV (Excel)

Export to CSV

What sections do you want to export ?

Métadonnées
Identification
General Aspects
Scientific investigator(s) (Contact)
Collaborations
Funding
Governance of the database
Additional contact
Type of database
Database objective
Population type
Dates
Size of the database
Data
Procedures
Promotion
Access
Select all | Invert selection | No selection

Which version do you want to export ?

send
Send
General
Identification
Detailed name Morbidity-mortality of COVID-19 in patients with chronic rheumatic disorder treated with immunosuppressants
Sign or acronym CORhum
CNIL registration number, number and date of CPP agreement, AFSSAPS (French Health Products Safety Agency) authorisation CNIL 2021796 v 0, CPP CPP2020-06-056b, NCT04426279
General Aspects
Medical area Internal medicine
Rheumatology
Study in connection with Covid-19 Yes
Pathology (details) systemic lupus erythematosus, spondyloarthritis, rheumatoid arthritis
Keywords systemic lupus erythematosus, spondyloarthritis, chronic rheumatic disorder, biological therapy, rheumatoid arthritis, immunosuppressants
Scientific investigator(s) (Contact)
Name of the director LETAROUILLY
Surname Jean-Guillaume
Address Service de Rhumatologie<br>Hôpital Roger Salengro<br>Rue Emile Laine<br>59037 Lille
Phone 320446926
Email jeanguillaume.letarouilly@chu-lille.fr
Organization Lille University Hospital
Collaborations
Participation in projects, networks and consortia Yes
Funding
Governance of the database
Sponsor(s) or organisation(s) responsible Lille University Hospital
Organisation status Public
Additional contact
Main features
Type of database
Type of database Study databases
Study databases (details) Not-repeated cross-sectional studies (except case control studies)
Database recruitment is carried out as part of an interventional study No
Database objective
Main objective Estimate morbidity-mortality associated with COVID-19 in patients with chronic rheumatic disorder (CRD) receiving immunosuppressants (IS).
Inclusion criteria Patients with RA on csDMARD +/- bDMARD or tsDMARD +/- corticosteroid therapy fulfilling 2010 ACR/EULAR classification criteria? Patients with SpA receiving bDMARD or tsDMARD +/- csDMARD +/- non-steroidal anti-inflammatory drugs fulfilling ASAS classification criteria? Patients with SLE receiving hydroxychloroquine +/- csDMARD +/- corticosteroid therapy +/- bDMARD fulfilling 2019 ACR/EULAR classification criteria
Population type
Age Adulthood (19 to 24 years)
Adulthood (25 to 44 years)
Adulthood (45 to 64 years)
Elderly (65 to 79 years)
Population covered Sick population
Pathology L93 - Lupus erythematosus
M05-M14 - Inflammatory polyarthropathies
Gender Male
Woman
Geography area Local
French regions covered by the database Nord - Pas-de-Calais Picardie
Data collection
Dates
Size of the database
Size of the database (number of individuals) [500-1000[ individuals
Details of the number of individuals 1500
Data
Database activity Current data collection
Type of data collected Clinical data
Presence of a biobank No
Procedures
Followed pathology
Promotion and access
Promotion
Access

Partners - FAQ - Contact - Site map - Legal notices - Administration - Updated on December 15 2020 - Version 4.10.05